This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/drugbank/drug/DB07375/identifier/chemspider/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07375/identifier/chebi/
n6http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07375/identifier/pdb/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n8http://linked.opendata.cz/resource/drugbank/drug/DB07375/identifier/pubchem-compound/
n4http://linked.opendata.cz/resource/drugbank/property/
n9http://linked.opendata.cz/resource/drugbank/drug/DB07375/identifier/pubchem-substance/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10http://linked.opendata.cz/resource/drugbank/drug/DB07375/identifier/drugbank/

Statements

Subject Item
n2:DB07375
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB07375 n13:DB07375
dcterms:title
5-BETA-ANDROSTANE-3,17-DIONE
adms:identifier
n8:440114 n9:99443846 n10:DB07375 n11:ANO n12:16985 n14:389114
n3:IUPAC-Name
n4:271B6565-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B656B-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B656A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B6567-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B6568-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B6569-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B6563-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B6561-363D-11E5-9242-09173F13E4C5 n4:271B6564-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B6562-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B6571-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B6572-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B656C-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B656D-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B656F-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B656E-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B6570-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B6577-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B6579-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B657A-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B6576-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B6575-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B6578-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B6566-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B6573-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B6574-363D-11E5-9242-09173F13E4C5